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Abstract.  Recycling of a  number of glycoproteins 
along the site of action of mannosidase I (the distal 
endoplasmic reticulum/cis-Golgi)  was followed in sev- 
eral different cell lines. Treatment of cells with 1-de- 
oxymannojirimycin (dMM) produced high mannose 
oligosaccharides at positions otherwise occupied by 
complex-type oligosaccharides in these glycoproteins. 
Conversion of high-mannose-type oligosaccharides to 
complex oligosaccharides of proteins initially synthe- 
sized in the presence of dMM was used as a  marker 
for recycling of glycoproteins along the site of action 
of dMM.  In contrast to findings reported by Snider 
and Rogers (Snider, M.  D.,  and O.  C.  Rogers.  1986. 
J.  Cell Biol.  103:265-275),  removal of dMM did not 
result in reconversion of high-mannose oligosaccha- 
rides to complex-type sugars, even after prolonged pe- 
riods of culture. We conclude that surface glycoproteins 
do not recycle through the cis-medial Golgi elements. 
NDOCYTOSIS of surface receptors is one of the mech- 
anisms by which the cell controls uptake of nutri- 
ents, and levels  of surface receptors.  Any stimulus 
delivered by hormones or growth factors may likewise be de- 
pendent on, or modulated by receptor-mediated endocytosis 
(7, 8).  The endocytotic pathway has been unraveled in con- 
siderable detail morphologically and biochemically (17, 26). 
Far less is known about the route taken by recycling receptors 
on their way back to the cell surface, because it is difficult 
to discriminate between newly synthesized receptors that are 
on their way to the plasma membrane, and recycling recep- 
tors that were already resident at the cell surface. 
In principle, the exocytotic aspect of the recycling pathway 
can be  studied, provided the  following conditions can be 
fulfilled. Receptors resident at the cell surface need to be 
tagged specifically; the label used should not perturb the re- 
cycling process  per  se;  traversing a  particular subcellular 
compartment  should  produce  a  detectable  change  in  the 
tagged  receptor.  Lactoperoxidase-catalyzed  iodination  of 
surface receptors in conjunction with neuraminidase diges- 
tion has been used to produce labeled, desialylated surface 
molecules that can report on traffic through the trans-Golgi 
(22). Under these circumstances, acquisition of sialic acid(s) 
is  interpreted as indicative of traversal through the trans- 
Golgi network. 
A second approach is to use modifications of N-linked gly- 
cans  as  produced by  oligosaccharide-trimming inhibitors 
(6).  Use of the mannosidase I inhibitor 1-deoxymannojiri- 
mycin (dMM) ~ results in retention of high-mannose oligo- 
1. Abbreviations  used in this paper:  dMM,  1-deoxymannojirimycin; Endo 
H, endoglycosidase H; ER, endoplasmic reticulum; FPLC, fast protein liq- 
uid chromatography; NANAse, neuraminidase; Tf, transferrin; Tfr,  trans- 
ferrin receptor; Tfr  ~mm, transferrin receptor synthesized in the presence of 
dMM. 
saccharides for those glycans normally converted to the com- 
plex type (5). In a pulse-chase experiment, surface receptors 
carrying high-mannose glycans as a  consequence of treat- 
ment with dMM can be delivered to the cell surface in a 
biosynthetically labeled form. If inhibition by dMM is re- 
versible,  then  these high-mannose glycans can  report  on 
recycling pathways involving the compartment which is the 
target of inhibition of dMM, i.e., the distal endoplasmic re- 
ticulum (ER) and cis-Golgi  (1, 5). 
Experiments of this type were performed by Snider and 
Rogers  (24),  who concluded that recycling molecules re- 
turned to the site of inhibitory action of dMM. These studies 
were  performed on  the  transferrin  receptor  (Tfr)  in  the 
erythroleukemic cell line K562. 
We are unable to confirm these findings for the Tfr not only 
in K562  cells,  but also  in  the human hepatoma cell line 
HepG2.  Moreover, class I antigens present on HepG2 and 
lymphoblastoid cell lines do not convert their high-mannose 
glycans to complex-type glycans in experiments of this type, 
nor do class II molecules in lymphoid cells. 
We conclude that, within the limits of resolution of these 
experimental systems, recycling of membrane proteins through 
the distal ER and cis-medial  Golgi is insignificant. 
Materials and Methods 
Cells and Cell Culture 
Human hepatoma cells (HepG2) were grown in DME supplemented with 
10%  FCS. Human lymphoblastoid cells (JY) and human erythroleukemia 
ceils  (K562)  were  grown  in  suspension  in  RPMI-1640  medium  sup- 
plemented with 10%  FCS. 
Antibodies 
The  following antibodies were used.  Rabbit anti-human  cq-antitrypsin; 
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Service, Amsterdam); mouse anti-human transferrin receptor (Mab 66 Ig 
10) (29); W6/32 (a mouse Mab recognizing HLA-A, -B, and -C locus prod- 
ucts) (16);  and a  rabbit anti-class II serum (13). 
Gel Electrophoresis 
SDS  gel  electrophoresis  (11) and  one dimensional isoelectric  focussing 
(one-dimensional IEF) were performed as described (12).  Immunoprecipi- 
tations were performed as described (3). 
Enzymatic Digestions and Glycosylation Inhibitors 
The immunoprecipitates were resuspended in 10 p.l digestion buffer (50 mM 
Na-citrate pH 5.5) containing 0. 2 % SDS and heated to 95°C for 5 min. After 
cooling, 2 mU endoglycosidase H (Endo H) (Boehringer Mannheim Diag- 
nostics, Inc., Houston, TX) in 10 p.1 digestion buffer was added. Digestion 
was carried out at 37°C for 20 h. The reaction was stopped by addition of 
SDS sample buffer. 
Digestions with neuraminidase type VIII (Sigma Chemical Co., St.  Louis, 
MO) were performed as described (12). 
dMM was synthesized using a new synthetic scheme (2) and was used 
as described (5) at a concentration of 1 mM. 
Reversibility of  Mannosidase I Inhibition by dMM 
in HepG2 Cells 
HepG2 cells were grown to subconfluency in 60-mm petri dishes in DME 
+  10%  FCS.  Before  labeling,  cells  were  incubated  for  30  min  in 
methionine-free RPMI medium. 
To determine the time required  for dMM to  fully exert its inhibitory 
effect, dMM (1  raM) was added to the culture medium (2 ml of medium 
per 60-ram dish), followed by metabolic labeling with 25 IxCi [35S]methio- 
nine per dish at 0, 60, and 300 min after addition of dMM. HepG2 cells 
were labeled for 20 min and chased for 30 min by addition of nonradioactive 
methionine to a  final concentration of 1 mM. Control cells were labeled 
with  25  I~Ci [35S]methionine for  20  rain,  followed by  a  30-rain chase. 
cq-antitrypsin was then immunoprecipitated from the culture medium. 
To establish the reversibility of inhibition by dMM, dMM (1 mM) was 
added to  the culture  medium for 5  h.  HepG2  cells were transferred to 
methionine-free medium (but also containing dMM) 30 min before removal 
ofdMM. To remove dMM, cells were washed three times with PBS at 37°C. 
Cells were again transferred to methionine-free medium, pulsed with 25 
p.Ci [35S]methionine  for 20 min, and chased for 30 rain. ch-antitrypsin was 
then immunoprecipitated from the culture medium. 
Recycling Experiment on HepG2 Cells 
HepG2 cells were grown to subconfluency in 60-ram petri dishes in DME 
+  10% FCS. Each dish was labeled in methionine-free RPMI medium with 
25 I.tCi of [3SS]methionine  for 5 h after the addition of dMM (1 raM). The 
incorporation of label was stopped by the addition of nonradioactive methio- 
nine to a  final concentration of 1 mM and the cells were chased for  1 h. 
Each dish was washed three times with PBS at 37°C and incubation was 
continued in DME  +  10%  FCS. At different timepoints (1, 3, 6,  12, and 
24 h) after dMM removal a dish was taken, cells were lysed in NP-40-con- 
raining lysis buffer (11), and Tfr as well as class I antigens were immunopre- 
cipitated as described (3). 
To verify that inhibition of mannosidase I activity by dMM was complete, 
one dish was taken immediately before dMM removal. Ceils were lysed with 
NP-40 lysis mix and Tfr and class 1 antigens were immunoprecipitated. 
To examine Tfr and class I antigens in control cells, one dish was labeled 
with 25  ~tCi of [35S]methionine for  5  h  in the absence of inhibitor and 
chased for 1 h. Cells were lysed with NP-40 lysis buffer and Tfr and class 
I were immunoprecipitated. 
Reversibility of  Mannosidase I Inhibition by dMM 
in K562 Cells 
K562 cells were maintained in RPMI  +  10%  FCS. Cells were labeled for 
5 h in methionine-free RPMI 1640 +  10% FCS at a density of 5.106 cells/ 
ml, using 25  I.tCi [35S]methionine/ml. Incorporation of label was stopped 
by addition of nonradioactive methionine to a final concentration of I mM, 
and incubation was continued (chase) for 60 min. For each chase time, ali- 
quots of 1 ml (5.106 cells) were taken. The experiment was otherwise per- 
formed as described for HepG2 cells. Cells were lysed in 1 ml NP-40-con- 
raining lysis buffer (12)  and Tfr was immunoprecipitated. 
Recycling Experiments on K562 Cells 
5.106 K562 cells were used for each condition and were labeled with 25 
I.tCi  [35S]methionine.  The  experiment  was  performed  as  described  for 
HepG2 cells, except that incubation after dMM removal was continued in 
RPMI  +  10%  FCS. 
Recycling Experiments JY  Lymphoblastoid Cells 
Recycling experiments involving JY cells were performed as described for 
K562 ceils. Class I and class II antigens were immunoprecipitated sequen- 
tially as described (13). 
Recycling of u~I-Tf  in HepG2 Cells 
Human transferrin Tf (T-2252; Sigma Chemical Co.) was iodinated to a 
specific activity of 9  p.Ci/p,g using chloramine T  iodination (9). 
HepG2  cells were  grown in 60-ram tissue culture dishes to  subcon- 
fluency.  For dMM treatment, cells were cultured for 72 h in the presence 
of 1 mM dMM. Control cells and dMM-treated cells were transferred to 
0°C and 12SI-Tf  was added (3 Ixg per dish for 10 min). Incubation was con- 
tinued on ice (resulting in binding, but not internalization, of Tf [10]) or at 
37°C (resulting in binding and uptake of t25I-Tf). To stop internalization, 
cells were transferred to 0°C. Unbound 125I-Tf  was removed by washing the 
cells three times with PBS at 0°C. Subsequently, surface bound t2SI-Tf  was 
removed by exposing the cells to a pH shock for 10-15 s with 1 ml 0.25 
M  HAc/0.5 M  NaCl pH 2.3. The cells were immediately neutralized with 
1 ml 1 M  NaAc and washed twice with PBS at 0°C. 5 ml DME was then 
added to each dish. The protocol described here for removal of surface Tf 
is essentially as described in reference I0. 
Incubation was then continued at 37°C, where recycling should result in 
the release of 125I-apotransferrin,  or at 0*C, where release of label is not 
due to recycling, but is nonspecific (i.e., due to iysis of and leakage from 
cells), l-ml samples were taken from the supernatant at different time points 
(t =  0, 2.5, 5,  15, 30 min). The amount of released t~I-Tf in the medium 
was measured by gamma counting. The condition where binding of 125I-Tf 
was allowed at 0°C, followed by removal of surface bound 125I-Tf, and in- 
cubation continued at 0°C represents the background of such an experiment 
(Fig.  2, curve labeled 0,0°C). 
When binding and uptake were allowed at 37°C (Fig. 2, curve 37, 37°C) 
or 0°C (curve 37, O°C), the difference between these two curves represents 
the amount of t25I-Tf released due to recycling. This experiment was car- 
ried out for control and dMM-treated cells. To verily that in dMM-treated 
cells all Tfr had the predicted type of N-linked glycan, Tfr was isolated from 
lactoperoxydase surface labeled (19)  control and dMM-treated cells, and 
analyzed by SDS-PAGE before and after Endo H  digestion. 
Labeling and A nalysis of Total N-linked Carbohydrates 
Labeling and analysis of total N-linked carbohydrates was performed essen- 
tially as described by Snider and Rogers (24).  Briefly,  4.107  K562 cells 
were labeled with 300 p.Ci 2[3H]mannose for 45 rain in either the presence 
or the absence ofdMM in RPMI containing 0.1 mg/ml glucose and 5 % FCS. 
Cells were chased for 3 h through addition of normal RPMI +  10%  FCS. 
Cells were washed three times with PBS in order to remove dMM, as de- 
scribed above. 
A  sample of 1,3.107 K562 cells was taken at timepoint 0' after chase, 
and after 18 h reculture in RPMI +  10%  FCS as well as in RPMI +  10% 
FCS supplemented with 20 mM mannose  to prevent reutilization of radioac- 
tive mannose. Cells were lysed in 1 ml NP-40 lysis buffer. Total lysates were 
digested with 5 mg of pronase per ml of lysate at 37°C. Every 2 h, 5 mg 
of pronase per ml of lysate was added and this was repeated  six times. 
Digested material was dialyzed (pore size of dialysis membranes 800 D) and 
samples were analyzed on a Mono Q column coupled to fast protein liquid 
chromatography (FPLC) equipment (LKB Instruments, Inc., Gaithersberg, 
MD) as described (28).  The radioactivity in the samples was determined 
by liquid spectrometry. 
Finally, 21.000 cpm were obtained from control cells at 0 h. After 18 h 
of reculture or 18 h of reculture in the presence of 20 mM mannose, 55 and 
50%,  respectively, of the label  was recovered.  From dMM-treated cells 
7,700 cpm was recovered at the 0-h timepoint. After 18 h of reculture or 
18 h of reculture in the presence of 20 mM mannose 58 and 49%, respec- 
tively, of the label was recovered. As judged from the amount of radioactiv- 
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beled mannose. 
We have  not observed any inhibitory effects of dMM on incorporation 
of [35S]methionine  for the three cell lines used in this study. 
Results 
To establish whether glycoproteins recycle under physiologi- 
cal conditions along the compartment(s) in which mannosi- 
dase I  is located (the endoplasmic reticulum/cis-Golgi)  (1, 
4), the following protocol was followed. Cells were labeled 
with  [35S]methionine  for 5  h  in  the  presence of the  man- 
nosidase I inhibitor dMM and chased for 1 h in order to allow 
passage of the radiolabeled proteins along the site of action 
of mannosidase I. The inhibitor dMM was removed by wash- 
ing,  resulting  in  a  reversal  of the  inhibition  imposed  by 
dMM, as will be shown below. Thus, all proteins passing the 
site of action of mannosidase I should now obtain their nor- 
mal  N-linked  carbohydrate type.  After removal of dMM, 
cells were analyzed at different timepoints, and the conver- 
sion  of high-mannose to  complex type N-linked  carbohy- 
drate  chains  on the  radiolabeled proteins  was  followed in 
time by glycosidase digestions  and  analysis by  isoelectric 
focussing.  Reconversion of high-mannose to complex-type 
N-linked carbohydrates can only occur through mannosidase 
I  activity,  followed by the  action  of GlcNAc transferase I 
and a-mannosidase II (6),  and thus would prove recycling 
through the cis-medial-Golgi. 
Inhibition by dMM Is Rapid and Reversible 
To perform the experiment as described above, we examined 
the reversibility of inhibition by dMM. HepG2 cells were la- 
beled  for  10  min  after  addition  or  removal  of dMM  at 
timepoints as indicated in Fig.  1 and chased for 30 min. ct~- 
antitrypsin was precipitated from the medium and half of the 
immunoprecipitates were treated with Endo H. Inhibition of 
mannosidase I  by dMM  results in high-mannose carbohy- 
drates,  and  thus  Endo  H  sensitivity of ¢tl-antitrypsin.  ¢h- 
antitrypsin normally carries complex type N-linked sugars 
and is Endo H  resistant (Fig.  1 A,  lanes 2  and 3). 
Fig.  1 a shows that dMM inhibited mannosidase I activity 
immediately after its addition (lanes 4 and 5). The inhibitory 
effect was reversible within 30 min after removal of dMM 
by washing (Fig.  1 a, lanes 10 and 11 ). To analyze this phe- 
nomenon for the Tfr, K562 cells werepulsed for 20 min and 
chased  for 60  min (see Fig.  1 b).  For K562  cells similar 
times of action of dMM were observed as for HepG2. For 
K562 also, this inhibition is reversible within 30 min. Note 
that Tfr is partly Endo H sensitive, in agreement with the ob- 
servation that Tfr contains both high-mannose and complex 
N-linked carbohydrates (14,  15, 25). Reversibility of the in- 
hibitory action of dMM was likewise established for the JY 
cell line, and was strictly comparable to our observations for 
K562 and HepG2 (results not shown). Our data are in agree- 
ment with those of Snider and Rogers (24). 
dMM Does Not Affect Binding of Tf to Tfr and 
Recycling of Tfr 
We established that changing the carbohydrate type by dMM 
treatment did not affect receptor recycling. We carried out re- 
cycling experiments for the HepG2 cell line based on pub- 
lished  protocols  as  described  in  detail  in  Materials  and 
Methods.  Fig.  2 a  shows that HepG2 cells, after uptake of 
Figure 1. Inhibition by dMM is reversible. Cells were exposed to 
dMM (1 mM final concentration) and labeled at various timepoints 
after exposure  to dMM.  Reversal of inhibition was measured  by 
removal of inhibitor by washing, and labeling at 30 and 60 min after 
removal. (a) HepG2 cells were exposed to 1 mM dMM and labeled 
for  10 min  with  [3sS]methionine at t  =  0  (lanes 4,  5),  t  =  60 
(lanes 6, 7), and t =  300 min (lanes 8, 9) after addition ofdMM. 
HepG2 cells were also labeled in the absence ofdMM (lanes 2, 3). 
After a 5-h exposure to dMM, the inhibitor was removed by wash- 
ing, and cells were labeled (for 10 min) at 30 (lanes 10, 11) or 60 
min (lanes 12, 13) after dMM removal. Cells were chased for 30 
min,  and cq-antitrypsin  was immunoprecipitated  from the medi- 
um.  Half of the  immunoprecipitates  were  treated  with  Endo  H 
(lanes indicated by  +).  Analysis was by SDS-PAGE (10% acryl- 
amide).  Control cells (lanes 2 and 3) were labeled and chased in 
the absence of dMM.  M, marker proteins:  92, 68, and 45 kD. (b) 
K562 cells were exposed to 1 mM dMM and labeled for 20 min 
with [35S]methionine at t = 0 (lanes 4, 5), t =  60 (lanes 6, 7), and 
t =  300 min (lanes 8, 9) after exposure to dMM.  K562 cells were 
also labeled in the absence ofdMM (lanes 2, 3). Cells were chased 
for 60 min. Tfr was immunoprecipitated and analyzed by Endo H 
digestion (lanes indicated by +) followed by analysis on SDS-PAGE 
(6% acrylamide).  After a 5-h exposure to dMM, the inhibitor was 
removed by washing, and cells were labeled and chased for 20 and 
60 min (lanes 10, 11), respectively, at 30 and 60 min (lanes 12, 13) 
after dMM removal. M, marker proteins: 92 and 68 kD, respectively. 
125I-Tf for 10 min at 37°C, released Tf only at 37°C and not 
at 0°C. The kinetics of release was indistinguishable for cells 
grown in  the presence of dMM  for 3  d  and control cells. 
There was no difference in binding of ~25I-Tf  to Tfr  dMM and 
Tfr, as measured on intact cells at 0°C (data not shown). To 
show that dMM had indeed quantitatively changed the car- 
bohydrate type of the Tfr, a biochemical analysis of surface- 
labeled Tfr was carried out and is shown in Fig. 2 b. HepG2 
cells cultured  in the presence or absence of dMM  for 3 d 
were surface iodinated.  The  Tfr was immunoprecipitated, 
digested  with  Endo  H,  and  analyzed by SDS-PAGE.  The 
Tfr  ~MM had a  lower apparent molecular mass than the Tfr, 
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by  control  and  dMM-treated  HepG2 
cells.  HepG2 cells  were incubated  with 
L'-~I-Tf  at 37 or 0°C for l0 min, and then 
transferred to 0°C.  Surface-bound  ~25I-Tf 
was removed by exposure  to low pH at 
0°C (10), and the low pH buffer was then 
replaced  with  ice-cold fresh  medium. 
Incubation was then continued on ice, or 
at  37°C,  and released  '2H-Tf was  mea- 
sured.  The first number over the curve 
indicates  the temperature  at  which ex- 
posure to 125I-Tf  took place,  the second 
number the temperature  at which release 
was measured.  Specific release of '25I-Tf 
takes place at 37°C only, and is similar 
in kinetics and quantity  for control cells 
(top) or cells  cultured  for 3 d in dMM 
(bottom). (b) All Tfr that can be surface 
labeled  in  dMM-treated  HepG2  cells 
carries  high-mannose  N-linked  oligo- 
saccharides  only.  Equal  amounts  of 
HepG2 cells (lanes 3 and 4) and HepG2 
cells cultured in the presence of 1 mM 
dMM for 72 h (lanes 5 and 6) were cell 
surface  iodinated.  The Tfr was precipi- 
tated  and  treated  with  (+)  or without 
Endo H.  Samples  were  analyzed on a 
6% SDS-PAGE. Lane 1, molecular mass 
markers.  Normal rabbit  serum control 
(NRS) from control cells (lane 2) as well 
as for dMM-treated HepG2 cells  (lane 
7) are shown.  Surface-labeled  Tfr from 
dMM-treated cells  is completely Endo 
H sensitive, resulting in a lower molecu- 
lar  mass after  digestion  than  similarly 
treated Tfr from control cells. M, marker 
lane:  92, 68, and 45 kD,  respectively. 
showing  that  3  d  of culture  in the  presence  of dMM  had 
changed the carbohydrate type of all Tfr that could be surface 
labeled. 
Having established that the inhibitory effect of dMM is re- 
versible, and that dMM treatment did not affect recycling of 
the Tfr in K562 and HepG2 cells, the recycling of glycopro- 
teins along the site of Mannosidase I  (the ER/cis-Golgi) (1, 
4)  was  followed  as  described  in  Materials  and  Methods. 
Three different cell lines were used: the cell line K562 (Tfr), 
the hepatoma cell line HepG2 (Tfr and class I antigens), and 
the Epstein-Barr virus-transformed cell line JY (class I and 
class II antigens). 
Do Transferrin Receptors in 1(562 Cells Return 
to the Site of  Action of  Mannosidase I? 
K562  cells,  labeled  for 5  h  in the presence  of dMM,  and 
recultured  for  various  periods  of time  in  the  absence  of 
dMM, were used as a source of Tfr. The immunoprecipitated 
Tfr  were  analyzed  after  digestion  with  Endo  H  on  SDS- 
PAGE. Equal amounts of radioactive,  immunoprecipitated, 
Tfr were loaded on gel.  Tfr from control cells  is partially 
Endo H sensitive, because it contains two high-mannose and 
one  complex-type  N-linked  oligosaccharide  (13,  14,  24). 
Tfr  dMM contains  only high-mannose  N-linked  oligosaccha- 
rides, and is therefore fully Endo H sensitive. Note the differ- 
ence in mobility between Tfr  dMM and Tfr (Fig.  3 a,  lanes 4 
and 5).  The difference in mobility between Tfr  dMM and Tfr 
is visible before, as well as after Endo H  digestion (Fig.  3 
b, lanes 4 and 5).  Tfr  dMM retains its full Endo H  sensitivity 
even after 24 h of reculture in the absence of dMM (Fig.  3 
b,  lane 11). 
Using IEF it is possible to monitor the addition of (nega- 
tively charged) sialic acids.  When the same set of samples 
shown in Fig. 3 a  and 3 b was analyzed by one dimensional 
IEF, no addition of sialic acids was demonstrable after 24 h 
of reculture in the absence of dMM, as judged from the com- 
plete absence of newly appearing, more acidic species of Tfr 
(Fig.  3  c). 
Does the Tfr Carry O-linked Glycans? 
We obtained evidence in support of the presence of O-linked 
sugars on the Tfr.  First,  the IEF pattern  of Tfr from con- 
trol cells before and after neuraminidase (NANAse) digestion 
is  inconsistent  with the presence of a  single complex-type 
N-linked glycan (Fig. 3 d, lane 2). An average of five, and a 
maximum of six or seven sialic acids can be deduced from 
the  complexity  of the  IEF  banding  pattern  and  NANAse 
digestions. This finding is incompatible with the presence of 
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sates after a recycling experiment  as described in Materials  and Methods.  (a) Tfr was analyzed from control cells before (C, lanes 3 and 
14) and after (C+,  lanes 4 and 15) digestion  with Endo H. Tfr  ~MM was analyzed similarly  (dMM,  lane 12; dMM÷, lane 13). Note the 
clear difference in mobility for dMM + and C+, and the reproducible  difference in mobility between C and the 0 timepoints after withdrawal 
of dMM (lane 5).  After 24 h of dMM withdrawal,  there  is no noticeable  shift  in mobility  of Tfr  dMM. For each sample,  equal  amounts 
of radioactivity  were loaded.  NRS, immunoprecipitation  with normal rabbit  serum; M, marker proteins:  92 and 68 kD, respectively.  (b) 
As a, but Tfr  dMM samples  taken after dMM withdrawal  were digested  with Endo H. Other samples  have been labeled  as for a. Note the 
difference  in mobility  between  the 24-h withdrawal  sample,  and the C÷  sample  (lanes//  and 12).  No conversion of Tfr  ~MM to Tfr has 
taken place.  For each sample,  equal amounts of radioactivity  were loaded.  (c) As for a, but immunoprecipitated  samples  were analyzed 
by one-dimensional  lEE  Lanes labeled  +  were subjected  to digestion  with  NANAse before lEE  Anode is at the bottom. Note the lack 
of newly appearing sialylated  forms of Tfr  dMM. The autoradiogram was deliberately  overexposed  to show that Tfr  dMM is not converted  to 
a form with a sialic  acid content equivalent  to Tfr (compare lanes  // and 13). The presence of sialic  acids on Tfr  dMM suggests that Tfr 
carries N- and O-linked glycans (see  text).  A shorter exposure  of lanes  1-5 is shown  in d. 
a single tri- or even tetraantennary complex glycan (14,  15, 
25).  Second, Tfr  dMM does not focus at the same position as 
Tfr or Tfr  dMM after NANAse digestion (Fig. 3 c, lanes 3 and 
5).  Treatment  with  dMM  reduces  the  average  number  of 
sialic acids to three.  Note that class I antigens, which carry 
only a  single N-linked glycan and do not contain O-linked 
sugars  (16)  are  indistinguishable  on  IEF  after  NANAse 
digestion and dMM treatment (Fig. 4). Thus, NANAse sen- 
sitivity on glycoproteins labeled in the presence of dMM can 
occur only if sialic acids are present on O-linked sugars. The 
position on IEF gels of NANAse-digested,  but not that of 
undigested  Tfr  aMM is  identical  to that of NANAse-digested 
Tfr.  Our data are therefore consistent with the presence of 
O-linked glycans containing an average of two to three sialic 
acids  on Tfr.  To our knowledge,  the presence  of O-linked 
sugars on Tfr has not been previously suggested. Our obser- 
vations would explain  why the position of migration of Tfr 
on IEF also differs for NANAse-digested Tfr,  and Tfr  °M~, 
in the report of Snider and Rogers (reference 24;  Fig.  5). 
HepG2 
Recycling  experiments  were  also  carried  out  for  HepG2 
cells,  with  results  essentially  similar  to those obtained for 
K562. Tfr as well as class I antigens were precipitated from 
equal amounts of TCA-precipitable radioactivity. No conver- 
sion to control-type Tfr was seen upon reculture of dMM- 
treated HepG2 cells. No species of Tfr carrying an increased 
number of sialic  acids could be detected upon reculture  in 
the  absence  of inhibitor  of dMM-treated  cells,  confirming 
the results obtained for K562  (Fig.  4,  left). 
We also analyzed whether reconversion of high-mannose 
glycans could take place  for another  membrane  glycopro- 
tein in HepG2  cells,  the HLA class I  antigens.  The single 
N-linked glycan carried by class I antigens is always of the 
complex type in control cells (16, 27). Note that dMM treat- 
ment results in the generation of class I heavy chains that are 
indistinguishable  by  IEF  from  NANAse-digested  control 
class I  molecules (Fig.  4,  right,  lanes  3  and 4). 
As was shown for Tfr,  class I molecules did not convert 
from  an  Endo  H-sensitive  to  an  Endo  H-resistant  form 
(results  not  shown)  nor  could  the  addition  of sialic  acids 
upon reculture  in the absence of dMM be substantiated  by 
IEF (Fig.  4,  right,  lanes 4-9). 
Reconversion of High-Mannose Oligosaccharides 
on Membrane Proteins in Lymphoid Cells 
To establish that the lack of conversion of high-mannose to 
complex-type sugars on HLA class I molecules was not re- 
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treated HepG2 cells does not 
result in reconversion of high- 
mannose N-linked glycans. A 
recycling experiment was car- 
ried out on HepG2 cells as de- 
scribed in Materials and Meth- 
ods, similar to the experiment 
described in Fig. 3. Immuno- 
precipitations  were  carried 
out from constant amounts of 
input radioactivity.  The  de- 
crease in amount of immuno- 
precipitated material  thus  in 
both  panels  reflects turnover 
of  surface-labeled  proteins. 
(Left) Analysis of Tfr by one- 
dimensional lEE No acquisi- 
tion of sialic acids is detect- 
able for Tfr  ~u even after 24 h 
of reculture. (Right) Analysis of HLA class I antigens by one-dimensional lEE No acquisition of sialic acid is detectable for class I heavy 
chains. Note that the pattern observed for dMM-treated material is identical to that observed for NANAse-digested control samples (C+). 
stricted to the HepG2 cell line, a similar experiment was car- 
ried out for the human lymphoblastoid cell line JY. Class I 
antigens have been reported to undergo recycling in lym- 
phoid cells (18).  For class I antigens in the JY cell line, no 
reconversion of high-mannose to complex-type oligosaccha- 
rides could be detected by acquisition of Endo H resistance 
(Fig. 5 a) upon reculture of dMM-treated JY cells in the ab- 
sence of inhibitor. 
A  similar analysis was performed for HLA class II anti- 
gens. These molecules consist of  an a chain, which normally 
caries a high-mannose and a complex-type oligosaccharide, 
and a 13 chain, which carries a single complex-type glycan 
(21).  In  experiments similar  to those described above for 
class  I  antigens,  no  acquisition  of sialic  acids  could  be 
documented even after 24 h  of reculture of dMM-treated 
cells in the absence of dMM (Fig. 5 b). 
Recycling of  Bulk N-linked Glycoproteins  along 
the ER/cis-Golgi 
We have been unable to demonstrate acquisition of complex- 
type sugars upon reculture of dMM-treated cells in the ab- 
sence of inhibitors. These findings extend to the Tfr for two 
different cell lines, HLA class I molecules for two cell lines, 
and HLA class II molecules for one cell line. These findings 
cannot exclude that certain other glycoproteins do recycle 
through the cis-Golgi. To address this problem, we labeled 
K562 cells with 2-[3H]-D-mannose in the presence and ab- 
sence of dMM for 45 min, and chased for 1 h.  Cells were 
recultured in the presence or absence of 20 mM mannose, 
to be able to observe the possible reutilization of labeled 
mannose  derived from  glycoprotein catabolism.  Samples 
were taken at 0 and 18 h after removal of dMM. Lysates were 
prepared and digested with pronase. Samples were analyzed 
through a Mono Q column as described (28), resulting in the 
separation of charged (complex) sialylated and noncharged 
(high-mannose) carbohydrates. 2-[3H]-D-mannose  cannot be 
subjected to epimerization into other sugars without losing 
its  label  and  mannose  is  only incorporated into N-linked 
carbohydrates. Fig. 6 shows the result of the analysis of these 
samples. A difference between the carbohydrate pattern from 
control and dMM-treated cells is apparent,  the fraction of 
complex carbohydrates (fractions  16--45)  found in  dMM- 
treated cells most probably being due to glycoproteins that 
escaped inhibition by dMM. However, after 18 h of reculture 
of dMM-treated cells,  no significant increase of complex- 
type carbohydrates is observed (compare right-sided graphs 
in Fig. 6), as is obviously also the case for the carbohydrate 
chain  from control cells (Fig.  6,  left-sided graphs).  Cells 
recultured in the presence of excess mannose showed radio- 
activity recovery reduced by 5 (labeled control cells) or 9% 
(cells labeled in the presence of dMM), indicating that some 
reutilization of label can take place. The distribution of label 
over the chromatographic profile was not altered by the inclu- 
sion  of excess mannose  in  the  medium  during  reculture. 
Thus for total glycoproteins in K562 cells, no conversion of 
high-mannose oligosaccharides to complex-type glycans is 
observed. Significant recycling along the cis-Golgi is there- 
fore unlikely. 
Discussion 
The routes traveled by recycling receptors have been particu- 
larly well defined, both biochemically and ultrastructurally 
as far as the endocytic portion of the pathway is concerned. 
Far less is known about the exocytic route(s) followed by re- 
cycling receptors. 
One report describes the addition of sialic acid to surface- 
labeled, neuraminidase-digested surface molecules, the Tfr 
(22). This finding was interpreted as evidence that recycling 
receptors pass through the compartment where sialyltrans- 
ferase is located, the trans-Golgi network. The kinetics of 
resialylation, when compared with the kinetics of recycling 
(22), indicate that only a fraction of recycling receptors is a 
substrate for sialyltransferases on a per cycle basis. 
Two recent reports claim that the cis-Golgi, the site of ac- 
tion of mannosidase I,  is also an integral part of the route 
taken by surface-derived recycling receptors. In one study 
(32), electron micrographical evidence supported the notion 
The Journal of Cell Biology, Volume  107, 1988  84 Figure 5. Glycans of HLA antigens from dMM-treated JY cells retain the high-mannose configuration upon reculture. A recycling experi- 
ment similar to those shown in Figs. 3 and 4 was carried out on JY cells. Immunoprecipitations  were carried out from constant amounts 
of input radioactivity. (.4) Analysis of HLA class I antigens by SDS-PAGE. Lanes indicated +  represent Endo H-digested samples. Other- 
wise the organization of the figure is as for Fig. 3. The disappearance of the class I heavy chain with time reflects its turnover in the course 
of the experiment.  (B) Analysis by IEF of class II antigens. Position of migration of the ct and 13 chains is indicated by brackets.  Note 
that the NANAse-digested samples show a pattern comparable to dMM-treated  class II antigens. Although there appears to be selective 
decay of some polypeptides,  no newly sialylated species arise even after 24 h. 
that Tfr, tagged at the cell surface with anti-Tfr antibodies 
or fragments thereof, traveled to the cis-Golgi within 10 min. 
After  30  rain,  distribution  of surface-tagged Tfr over the 
different Golgi compartments was random.  This suggested 
selective transport of recycling receptors,  first through the 
cis-Golgi, followed by transport through the trans-Golgi net- 
work.  The  second  study  used  techniques  similar to those 
used in the present report (24).  Surface Tfr, synthesized in 
the presence of dMM,  were analyzed with respect to their 
type of N-linked glycan after reculture of cells in the absence 
of dMM. Any reconversion of high-mannose glycans (being 
the result of inhibition by dMM) to complex-type N-linked 
glycans analyzed by acquisition of Endo H  resistance or of 
sialic  acid  heterogeneity  would  be  indicative  of  passage 
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Figure 6.  Analysis of total N-linked glycans 
of K562 cells.  K562 cells were labeled with 
2-[3H]mannose in the absence (/eft s/de) and the 
presence of  dMM (right side). Total cell lysates 
were digested with pronase and analyzed by 
FPLC on a Mono Q column. Radioactivity in 
each fraction was determined by liquid spec- 
trometry.  The radioactivity  in each  fraction 
was then calculated as the percentage of total 
number of counts per minute recovered for the 
entire elution profile. (Top) Total pattern after 
0 h. (Center) Total pattern after 18-h reculture. 
(Bottom) Total pattern after  18-h reculture in 
the presence of 20 mM mannose. Noncharged 
species are eluted first from the column (frac- 
tions 1-10, as deduced from NANAse treatment 
of sialylated oligosaccharides). Fractions  16- 
24, 24-31, 31-40, and 40-45 are the one sialic 
acid, two sialic acid, three sialic acid, and four 
sialic acid-containing species, respectively, as 
determined through FPLC analysis of glyco- 
peptides  derived  from  0h-acid glycoprotein 
before and after NANAse digestion. Abscissa, 
fraction  number;  ordinate,  percent  of total 
counts. 
along the site of mannosidase I, the endoplasmic reticulum/ 
cis-Golgi  up to the site of action of GIcNAc transferase I 
and mannosidase I, the medial Golgi. Apart from the fact that 
both studies (24, 31) report widely different kinetics for the 
delivery of recycling glycoproteins to the cis-medial vs. the 
trans-Golgi,  possibly due to the different experimental pro- 
tocols used, there are several problems of interpretation with 
the latter study.  First, because the inhibitory effect of dMM 
is completely reversible (24;  this  study,  Fig.  1),  Tfr pro- 
duced upon reculture of cells labeled in the presence of dMM 
should be  indistinguishable  from control Tfr if recycling 
through the cis-Golgi would indeed occur. This is obviously 
not the case even after 20 h of reculture (reference 24; Figs. 
3-5).  Second,  the  analysis  of bulk  [3H]mannose-labeled 
glycopeptides in dMM-treated cells before and after recul- 
ture in the absence of dMM suffers from the fact that after 
18 h of reculture, only 20%  of the label present at 0 h of 
reculture was actually recovered in the study of Snider and 
Rogers  (24).  There is  no net  increase  in  radioactivity in 
complex  oligosaccharide-containing  fractions.  Thus,  the 
argument  in  support of reconversion of high-mannose  to 
complex-type oligosaccharides is indirect, because it rests 
on the assumption that there is no selective breakdown of 
high-mannose  oligosaccharide-containing structures.  It  is 
remarkable that the relative loss of label in  [3H]mannose- 
labeled Tfr is substantially less during reculture than that 
observed for bulk glycopeptides (compare Figs. 3 and 6 in ref- 
erence 24).  Third,  even upon  reculture of [3H]mannose- 
labeled cells that had never been exposed to dMM, following 
the  same  experimental protocols,  the  relative increase  in 
complex-type sugars over the  18-h reculture period was of 
the same order of magnitude as that observed for the recul- 
ture of dMM-treated cells (compare Figs. 4 and 7 in refer- 
ence 24). Because the former figures must necessarily repre- 
sent completion of high-mannose oligosaccharide trimming 
and terminal carbohydrate processing of newly synthesized 
labeled molecules, corrections should be applied to values 
observed for reculture of dMM-treated cells. The increase 
in complex-type oligosaccharides observed for control cells 
(Fig. 7 in reference 24) represents the experimental error of 
the system, and, as stated, this error is of the same order of 
magnitude as the experimentally observed values.  Finally, 
even though Tfr has a recycling time which is amongst the 
shortest reported (5 min [30]), the rate of reconversion of Tfr 
high-mannose glycans, upon reculture of dMM-treated cells, 
is lower than that of bulk oligosaccharides (more than 6 and 
4 h, respectively; Figs.  3 and 6 of reference 24). 
We were able to confirm (24), for all three cell lines tested, 
the complete reversibility of inhibition by dMM.  We also 
confirmed that cells,  grown in  the  presence of dMM  for 
periods  sufficiently long to produce Tfr containing exclu- 
sively high-mannose N-linked oligosaccharides on the cell 
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Tfr binding and recycling of Tfr are concerned. Surface ex- 
pression  of  Tfr,  as  measured  by  immunoprecipitation  of 
surface-iodinated  material,  was  quantitatively  comparable 
for control and dMM-treated cells. 
Our observations that Tfr  dMM is clearly distinct from Tfr 
upon  IEF  deserves  comment.  We  suggest  that  O-linked 
glycosylation of Tfr takes place,  and that this modification 
has been overlooked thus far. The difference in IEF banding 
pattern observed between dMM-treated and control Tfr can 
be abolished by NANAse treatment. Our results do not sup- 
port the conclusions of Snider and Rogers (24) as far as re- 
turn of recycling glycoproteins to the site of action of manno- 
sidase  I  is concerned.  We have been unable to detect any 
reconversion of high-mannose oligosaccharides on Tfr from 
dMM-treated cells after periods of reculture as long as 24 h 
as found earlier, surprisingly also by Snider and Rogers (23). 
Our observations  were  made  in  three dissimilar  types  of 
cells:  the human erythroleukemic cell line K562, the same 
cell line as was used by Snider and Rogers; the human lym- 
phoblastoid cell line JY; and the human hepatoma cell line 
HepG2.  No reconversion could be detected either for class 
I  histocompatibility  antigens  in  the  lymphoblastoid  and 
hepatoma cell lines,  or for class II histocompatibility anti- 
gens in the lymphoblastoid cell line. We could confirm and 
extend our earlier experiments of this type on lymphoid cells 
that were restricted to shorter periods of observation (12 h) 
(20). We therefore disagree with the notion (24) that all gly- 
coproteins return to the site of action of mannosidase I with 
half-times of 4-6 h. In fact, one cannot fail to be impressed 
with the precision with which the cell keeps these potentially 
intersecting pathways separate, as judged from the biochemi- 
cal  evidence  presented  here.  Even though small  peptides, 
when added to intact cells, can be transported back as far as 
the ER (31) where they then enter the secretory pathway, the 
experiments reported here show that for Tfr, HLA class I and 
II  antigens  as  well  as  bulk  glycoproteins,  the  cis/medial 
Golgi is unlikely to be revisited for the better part of their 
lifetime. 
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